A clinical trial of a form of birth control that suppresses sperm production while maintaining testosterone levels is currently in its fourth year at UC Davis Health.
UCSF-led research shows smartphone cognitive testing is comparable to gold-standard methods and may detect FTD in gene carriers before symptoms start.